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Abstract
Background:  In eukaryotic cells, proteins are translocated across the ER membrane through a
continuous ribosome-translocon channel. It is unclear to what extent proteins can fold already
within the ribosome-translocon channel, and previous studies suggest that only a limited degree of
folding (such as the formation of isolated α -helices) may be possible within the ribosome.
Results:  We have previously shown that the conformation of nascent polypeptide chains in transit
through the ribosome-translocon complex can be probed by measuring the number of residues
required to span the distance between the ribosomal P-site and the lumenally disposed active site
of the oligosaccharyl transferase enzyme (J. Biol. Chem 271: 6241-6244).Using this approach, we
now show that model segments composed of residues with strong helix-forming properties in
water (Ala, Leu) have a more compact conformation in the ribosome-translocon channel than
model segments composed of residues with weak helix-forming potential (Val, Pro).
Conclusions:  The main conclusions from the work reported here are (i) that the propensity to
form an extended or more compact (possibly α -helical) conformation in the ribosome-translocon
channel does not depend on whether or not the model segment has stop-transfer function, but
rather seems to reflect the helical propensities of the amino acids as measured in an aqueous
environment, and (ii) that stop-transfer sequences may adopt a helical structure and integrate into
the ER membrane at different times relative to the time of glycan addition to nearby upstream
glycosylation acceptor sites.
Background
Most eukaryotic secretory protein are translocated
across the membrane of the endoplasmic reticulum (ER)
through a continuous ribosome-translocon channel that
is sealed to the cytoplasmic compartment and open to-
wards the ER lumen [1]. Recent structural studies of ri-
bosomes from Haloarcula marismortui suggest that the
channel through the large ribosomal subunit is ~ 100 Å
long and 10-20 Å wide [2], and the same appears to hold
true also for yeast and rabbit ribosomes [3]. The internal
diameter of the translocon channel present in dog pan-
creas microsomes has been estimated to be 40-60 Å [4].
It is unclear to what extent proteins can fold already
within the ribosome-translocon channel; studies on ri-
bosome-nascent chain complexes suggest that only a
limited degree of folding (such as the formation of isolat-
ed  α -helices) may be possible within the ribosome
[5,6,7].
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In this paper, we report experiments where we have used
truncated nascent chains trapped within the ribosome-
translocon complex to measure the number of residues
of nascent polypeptide (dP-O) required to span the dis-
tance between the P-site on the ribosome (located at the
entrance to the ribosomal channel) and the active site of
the oligosaccharyl transferase (located near the lumenal
end of the translocon channel). By placing 18-residue
long stretches of model sequences (e.g., L17V, A17V, V18,
P18) in locations that are either within the ribosome or
the translocon in the truncated nascent chain we find
that dP-O values tend to fall near either 65 or 70 residues,
and we equate these two values with extended and helical
conformations of the model stretches, respectively. We
conclude that the L17V and A17V segments tend to form
α -helices both in the ribosomal and translocon parts of
the channel, while the V18, P18, and the transmembrane
segment from glycophorin A (GpA) have more extended
conformations. Since the GpA transmembrane segment
(and, presumably, the V18 segment) is helical in the lipid-
embedded form of the protein [8, 9], this suggests that a
hydrophobic segment with low helix potential in water
may enter the translocon as an extended stretch of
polypeptide and will only fold into a helical conformation
upon lateral exit from the translocation channel into the
lipid bilayer. On the other hand, stretches in the nascent
polypeptide with strong helix propensity but insufficient
hydrophobicity to insert into the lipid bilayer (e.g., A17V)
may form individually stable α -helices already in the ri-
bosomal channel.
Results
The glycosylation mapping assay
The number of residues required to span the distance be-
tween the ribosomal P-site and the active site of the oli-
gosaccharide transferase (OST) can be conveniently
measured by a previously described "glycosylation map-
ping" assay [10]. Ribosome-nascent chain complexes at-
tached to the ER translocon are generated by translation,
in the presence of dog pancreas microsomes, of truncat-
ed mRNA molecules coding for a membrane protein (E.
coli Lep) lacking a 3' stop codon, Fig. 1A. A series of
neighboring truncation points on the mRNA is chosen
such that a unique Asn-Ser-Thr acceptor site for N-
linked glycosylation is moved from a position ~ 60 co-
dons to a position ~ 75 codons away from the 5' end of the
mRNA, and the degree of glycosylation is measured for
each truncated chain. As we have shown previously [10],
glycosylation of the ribosome-attached nascent chain is
generally observed when the glycosylation acceptor site
is placed at a distance of ~ 65-75 residues away from the
ribosomal P-site. As the maximum level of glycosylation
typically observed for the truncated Lep constructs dis-
cussed below is ~ 60%, we define the "critical" number of
residues (dP-O) required to span the distance between
the P-site and the OST active site to be the chain length
where 30% glycosylation is observed.
Figure 1
Determination of the minimum number of residues required to span the distance between the ribosomal P-site and the active
site of oligosaccharide transferase (dP-O values). Ribosome-bound truncated nascent chains of different lengths are generated
by in vitro translation, in the presence of dog pancreas microsomes, of mRNAs lacking a stop-codon. The dP-O value is the
number of residues between the Asn residue in an Asn-Ser-Thr glycosylation acceptor site (Y) and the C-terminal end of the
nascent chain required for half-maximal glycosylation of the acceptor site. (A) The model protein used in this study (E. coli Lep)
has two transmembrane segments (black) and a C-terminal lumenal domain. The approximate number of residues in an
extended chain needed to span the indicated distances are given [10]. (B) Truncated Lep with a model segment (white) placed
in the ribosome. The glycosylation site is placed in position 178 in Lep. (C) Truncated Lep with a model segment (white) placed
in the translocon. The glycosylation site is placed in position 200 in Lep. In both panels B and C, the model segment is intro-
duced between positions 214 and 220 in Lep.BMC Cell Biology (2000) 1:3 http://www.biomedcentral.com/1471-2121/1/3
Ala- and Leu- but not Val- or Pro-based segments have a 
compact conformation both in the ribosome and the trans-
locon
In the earlier study refereed to above [10], we found that
65 residues from the C-terminal P2 domain of wild type
Lep are required to span the distance between the P-site
and the OST active site, i.e. dP-O = 65. We further found
that when a model hydrophobic stretch with the se-
quence ...QQQL17VKKKK... was inserted 15 residues
downstream of the glycosylation site (i.e., in a location
that is largely inside the translocon when the nascent
chain is long enough to allow glycosylation, Fig. 1C), dP-
O increased to 71 residues, suggesting a more compact,
possibly  α -helical, conformation of the L17V segment
compared to the corresponding stretch from the
wildtype P2 domain. In a fully extended chain (~ 3.3 Å
per residue), approximately 11 residues need to be con-
verted to an α -helix (~ 1.5 Å per residue) to account for
the observed change in dP-O of ~ 6 residues.
Here, we have extended these studies, both by analyzing
a wider selection of model segments (V18, A17V, P18, and
the transmembrane α -helix from GpA) and by changing
the position of the glycosylation site relative to the model
segment such that the model segment is located within
the ribosome rather than the translocon at chain lengths
around the dP-O value, Fig. 1B. Results for the two Val-
based constructs with the hydrophobic stretch in the ri-
bosome (upper panel) and in the translocon (lower pan-
el) are shown in Fig. 2A. In both cases, dP-O  ≅  64
residues, Fig. 2B, i.e., close to the value found for wild
type Lep. The results for the GpA and P18 constructs are
similar, Fig. 2B, with dP-O ≅  65 residues. In contrast, the
dP-O values for the L17V and A17V segments are 70-71 res-
idues when they are present in the ribosome, and some-
what larger (~ 73 residues) for L17V in the translocon,
Fig. 2B. Assuming that an increase in dP-O corresponds
to a more compact conformation of the model segment,
we conclude that the L17V and A17V segments have a
compact, possibly helical, conformation when located in
the ribosome-translocon channel, while the V18, P18, and
GpA segments are more extended.
The differences in dP-O values do not correlate with the 
ability of the model segments to insert into the ER mem-
brane
To assess the ability of the model segments to insert into
the ER membrane (i.e., their stop-transfer function), a
second glycosylation acceptor site was added at the C-
terminal end of the protein (see Methods). As shown in
Fig. 3A, model segments with efficient stop-transfer
function will only be glycosylated on the upstream accep-
tor site, while those lacking stop-transfer function will be
glycosylated on both sites. Since acceptor sites located
close to the C-terminus of a protein are only about 30%
glycosylated even if efficiently translocated into the ER
lumen [11], we expect a mixture of singly and doubly gly-
cosylated molecules in the latter case.
As seen in Fig. 3B, the L17V and V18 constructs were gly-
cosylated on only one site, while 19% and 27% of the A17V
and P18 constructs were doubly glycosylated, respective-
ly. Protease treatment of microsomes also demonstrated
that only a small fragment (corresponding to the H2-V18
region) was protected in the V18 construct while a major
part (corresponding to the H2-P2 region) of wild type
Lep was protected inside the microsome, Fig. 3C. Thus,
although the V18 and GpA (8) segments do not appear to
fold into a compact conformation inside the ribosome-
translocon channel, they are efficient stop-transfer se-
quences. In contrast, the A17V sequence adopts a com-
pact (possibly α -helical) conformation in the channel,
but has little or no stop-transfer function. The L17V seg-
ment is both compact and an efficient stop-transfer se-
quence, while the P18 segment has an extended
conformation (possibly forming a poly-proline II helix
with a rise of 3.2 Å per residue [12], very close to the rise
of ~ 3.3 Å per residue for a fully extended chain) and no
stop-transfer function.
Poly-Val and poly-Leu TMH segments behave differently 
during integration into the ER membrane
Given that all stop-transfer sequences, once integrated
into the membrane, are expected to form transmem-
brane α -helices [13], the extended conformation of the
V18 and GpA model segments in the translocon channel
was somewhat surprising. To study this further, we de-
termined the "minimal glycosylation distance" (MGD)
for the full-length V18 and A17V constructs, and also for a
construct where the third Val residue from the N-termi-
nal end of the V18 stretch had been changed to Pro.
The MGD value is defined as the minimum number of
residues required to bridge the distance between the lu-
menal end of a hydrophobic transmembrane segment in
a membrane protein and the OST active site [14], Fig. 4A.
MGD measurements can be used to roughly position the
lumenal end of a transmembrane segment relative to the
ER membrane by comparison to MGD values for trans-
membrane helices where the position relative to the lipid
bilayer has been derived from various biophysical exper-
iments [15, 16]. In our previous studies, we have mainly
measured MGD values for poly-Leu based sequences. As
an example, the glycosylation profile for the L17V con-
struct is shown in Fig. 4B, yielding an MGD value of 15.7
residues [14].
Since, as shown above, the A17V construct is efficiently
translocated into the lumen of the microsomes, it is not
expected to have a "minimal glycosylation distance". In-BMC Cell Biology (2000) 1:3 http://www.biomedcentral.com/1471-2121/1/3
deed, all A17V-based glycosylation mutants tested are
60%-80% glycosylated, Fig. 4B. Interestingly, the V18
construct, which, like the L17V construct, forms a trans-
membrane segment, nevertheless has a glycosylation
profile that is clearly distinct from that of the L17V con-
struct: an initial drop from ~ 80% to ~ 40% glycosylation
at roughly the same glycosylation distance as L17V (~ 15.5
residues) is followed by a plateau, and background levels
of glycosylation are approached only at a glycosylation
distance of ~ 10.5 residues. One possible interpretation
is that there are two populations of V18 molecules at the
time when the glycan moiety is added to the growing nas-
cent chain: one that has a similar disposition relative to
the OST active site as the L17V molecules (i.e., presuma-
bly α -helical and membrane-integrated with an MGD
value of ~ 15.5 residues) and one with a significantly
smaller MGD value (~ 10.5 residues).
To test this idea further, we also analyzed a construct
where the third Val residue in the V18 segment was
changed to Pro. We have previously shown that the in-
troduction of a Pro residue in corresponding positions in
a L23V transmembrane segment leads to a reduction in
the MGD value of about 2.5 residues, presumably as a re-
sult of a break in the poly-Leu α -helix caused by the Pro
residue [14]. Indeed, the initial drop in the glycosylation
profile for the V18(P3) construct was ~ 2 residues, Fig.
4B, while the shift in the location of the second drop was
only ~ 1 residue. This is consistent with the possibility
that V18 molecules with MGD ~ 15.5 residues indeed
have already formed a transmembrane α -helix at the
time of glycosylation, whereas the remaining ones have
not. More detailed kinetic studies will be needed to fur-
ther substantiate this idea.
Discussion
In this paper, we have analyzed the conformation of
model polypeptide segments as they traverse the ribos-
ome-translocon channel during translocation across the
ER membrane. The study extends previous data, from
Figure 2
Determination of dP-O values for constructs where a model polypeptide segment has been inserted into the middle of the C-
terminal P2 domain of Lep. (A) Two constructs with a ...QQQV18KKKK... model segment in the C-terminal domain were trans-
lated in vitro in the absence (-) and presence (+) of rough dog pancreas microsomes (RM). The 3' codon in the truncated mRNA
was placed d codons downstream of the Asn residue in the Asn-Ser-Thr glycosylation acceptor site. The Asn residue in the
acceptor site was placed in lep codon 178 (upper panel) or 200 (lower panel), and the model segment was inserted between lep
codons 214 and 220 in both constructs. For the indicated range of d values, the model segment is located in the ribosome
(upper panel) or in the translocon (lower panel). Non-glycosylated and glycosylated molecules are indicated by black and white
dots, respectively. (B) Glycosylation profiles for constructs with model segments composed of the indicated residues flanked by
QQQ....KKKK. The Asn residue in the acceptor site was placed in lep codon 178 (upper panel) or 200 (lower panel), and the
model segment was inserted between lep codons 214 and 220 in all constructs. Half-maximal glycosylation (30%) is indicated by
the horizontal line.BMC Cell Biology (2000) 1:3 http://www.biomedcentral.com/1471-2121/1/3
which we concluded that a segment from the globular P2
domain of the E. coli leader peptidase (Lep) protein most
likely traverses the ribosome-translocon channel as an
extended chain, whereas a model L17V segment placed in
the P2 domain adopts a more compact, possibly α -heli-
cal, conformation when placed in the translocon part of
the channel [10].
The main conclusions from the work reported here are
(i) that the propensity to form an extended or more com-
pact (possibly α -helical) conformation in the ribosome-
translocon channel does not depend on whether or not
the model segment has stop-transfer function, but rather
seems to reflect the helical propensities of the amino ac-
ids as measured in an aqueous environment, and (ii) that
stop-transfer sequences may adopt a helical structure
and integrate into the ER membrane at different times
relative to the time of glycan addition to nearby up-
stream glycosylation acceptor sites.
Conclusion (i) follows from the observation that the A17V
and L17V model stretches - which are composed of resi-
dues that are strong helix-formers in an aqueous envi-
ronment [17] - both adopt a compact conformation in the
ribosome-translocon channel (Fig. 2), whereas the V18
and GpA model segments do not. Val has a low helix po-
tential in water but readily forms helices in micellar and
vesicular media [9, 17], and the GpA segment also in-
cludes a number of residues with low helix potential in
water (Gly, Val, Ile, Thr). The A17V segment does not
have stop-transfer function, as previously found for sim-
ilar constructs composed of up to 19 Ala residues [18],
while L17V and V18 do (Fig. 3).
The known dimensions of the ribosomal channel (mini-
mum diameter 10-20 Å [2, 3]) are consistent with the
formation of an α -helix, but would not allow bigger
structures to form. The walls of the ribosomal channel
are mostly composed of RNA and have a hydrophilic
character, suggesting that they do not interact strongly
with hydrophobic segments in the nascent polypeptide
chain. Our results are also consistent with a recent study
where it was found that the N-termini of ribosome-at-
tached nascent proteins become accessible to antibodies
at different chain-lengths depending on the protein [5],
also suggesting different degrees of structure formation
within the ribosome channel. The reported size of the
channel in the mammalian ER translocon is considera-
bly larger (40-60 Å diameter [4]), and would seem to al-
low the formation of larger folded structures; we see no
evidence for this, however.
Figure 3
Determination of stop-transfer activity of different full-length constructs. (A) Model segments (white) lacking stop-transfer
activity are translocated into the ER lumen and both glycosylation acceptor sites become modified (left). For model segments
with stop-transfer function, only the upstream site will become modified (right; Y denotes a glycosylated site, Φ  a non-glyco-
sylated site). The C-terminal glycosylation site is 6 residues away from the C-terminus of the protein (see Materials and Meth-
ods). (B) In vitro translation in the absence (-) and presence (+) of rough dog pancreas microsomes (RM) of constructs with the
indicated model segments. Non-glycosylated and mono- and di-glycosylated molecules are indicated by a black dot, a white dot,
and two white dots, respectively. (C) Proteinase K (PK) treatment of microsomes carrying in vitro translated wild type Lep (left
panel) or the full-length V18 construct (right panel). The detergent Triton X-100 was included to dissolve the microsomal
membrane in lanes 4 and 8. Non-glycosylated and glycosylated molecules are indicated by a black dot and a white dot, respec-
tively. Protease-protected fragments are indicated by a white square.BMC Cell Biology (2000) 1:3 http://www.biomedcentral.com/1471-2121/1/3
The second conclusion, that stop-transfer sequences
may adopt a helical structure and integrate into the ER
membrane at different times relative to the time of gly-
can addition to nearby acceptor sites, is tentative and
based on the finding that the L17V stop-transfer segment
(which has a compact structure in the translocon chan-
nel) has a well-defined MGD value of ~ 15 residues, while
molecules containing the V18 stop-transfer segment
(which has an extended conformation in the translocon
channel) appear to be characterized by two distinct MGD
values (~ 15 and ~ 10 residues), Fig. 4. By comparison to
the L17V result and based on the observation that a V →
P mutation near the N-terminal end of the V18 segment
causes a rather large drop in the larger of the two MGD
values (as would be expected if a transmembrane α -helix
was broken by the Pro residue), we suggest that the V18
segment in the population with MGD ~ 15.5 residues is
helical and membrane-integrated whereas the popula-
tion with MGD ~ 10.5 residues is not. It is thus possible
that we have been able to catch the V18 molecules in the
process of converting from an extended conformation in
the translocon channel to a helical, membrane-embed-
ded state. This interpretation is broadly consistent with
the results of a recent study [19], where it was shown that
more hydrophobic transmembrane segments move from
the translocon channel into the lipid bilayer more easily
(and thus presumably more rapidly) than less hydropho-
bic segments.
In summary, it appears that our approach using engi-
neered glycosylation sites, truncated nascent chains, and
different model polypeptide sequences makes it possible
to characterize the conformational propensities of differ-
ent polypeptide segments during translocation across
and integration into the ER membrane. Our results also
point to the necessity to carry out a careful analysis of the
glycosylation profile when MGD values are used to infer




Unless otherwise stated, all enzymes as well as plasmid
pGEM1, The RiboMAX SP6 RNA polymerase system,
and rabbit reticulocyte lysate were from Promega (Mad-
ison, WI) or New England Biolabs (Boston, MA). T7 DNA
polymerase, Taq polymerase, [35S]-Met, [14C]-methylat-
ed marker proteins, ribonucleotides, deoxyribonucle-
otides, dideoxyribonucleotides, and the cap analog
m7G(5')ppp(5')G were from Amersham-Pharmacia
(Uppsala, Sweden). The PCR purification and RNeasy
RNA clean up kits were from Qiagen (Hilden, FRG). The
PCR mutagenesis kit was from Stratagene (La Jolla, CA).
Proteinase K was from Boehringer Mannheim GmbH
(Mannheim, Germany). PMSF (phenylmethylsufonyl
fluoride) was from ICN Biochemicals Inc (Aurora, Ohio).
Puromycin was from Sigma (St. Louis, Missouri). Oligo-
nucleotides were from Kebo Lab and Cybergene (Stock-
holm, Sweden).
DNA manipulations
Site-specific mutagenesis was performed according to
the method of Kunkel [20, 21] or by PCR. All mutants
were confirmed by sequencing of plasmid DNA. All clon-
ing steps were done according to standard procedures.
Construction of full-length and truncated Lep glycosyla-
tion mutants
Insertion of the model sequences QQQL17VKKKK,
QQQA17VKKKK, QQQV18KKKK, and QQQP18KKKK and
Figure 4
Determination  of  the  "minimal  glycosylation  distance"
(MGD). (A) The MGD is defined as the minimum number of
residues required to bridge the distance between the lume-
nal end of a transmembrane segment (white) and the active
site of oligosaccharyl transferase (Y denotes a glycosylated
site, Φ  a non-glycosylated site). (B) MGD measurements for
constructs with the indicated model segments. Half-maximal
glycosylation (40%) is indicated by the horizontal line. The
MGD value is counted from the first polar residue before the
transmembrane segment (Gln) up to the acceptor Asn resi-
due as in [14].BMC Cell Biology (2000) 1:3 http://www.biomedcentral.com/1471-2121/1/3
the transmembrane helix from glycophorin A MITLIIF-
GVMAGVIGTILLISYGIKKKKH (GpA-derived residues
underlined) into the P2 domain of Lep was performed by
introducing BclI and NdeI restriction sites in lep codons
214 and 220, respectively. Double-stranded oligonucle-
otides coding for the model sequences were then cloned
between the BclI and NdeI restriction sites. Site-specific
mutagenesis was used to introduce an Asn-Ser-Thr glyc-
osylation acceptor site in lep codons 200 and 178 and to
introduce the restriction enzyme cleavage sites. For clon-
ing into and expression from the pGEM1 plasmid, the 5'
end of the lep gene was modified by introducing a Kozak
consensus sequence [22] for enhanced translation and a
XbaI site for cloning: ...ATAACCCTCTAGAGCCACCAT-
GGCGAATATG...(XbaI site and initiator codon under-
lined). Mutants of Lep were cloned into pGEM1 behind
the SP6 promoter as an XbaI-SmaI fragment.
Templates for in vitro transcription of truncated mRNA
with or without a 3' stop codon were prepared using PCR
to amplify fragments from pGEM1 plasmids containing
the relevant Lep constructs. The 5' primer was the same
for all PCR reactions and had the sequence 5'-TTCGTC-
CAACCAAACCGACTC-3'. This primer is situated 210
bases upstream of the translational start, and all ampli-
fied fragments thus contained the SP6 transcriptional
promoter from pGEM1. The 3' primers were designed ac-
cording to the desired C-terminal end of the truncated
protein and either contained no stop codon or a TAG stop
codon. All primers were designed to have approximately
the same annealing temperature. PCR amplification was
performed with a total of 30 cycles using an annealing
temperature of 52 ° C. The amplified DNA products were
purified using the Qiagen PCR purification kit as de-
scribed in the manufacturers protocol and verified on a
1.2 % agarose gel.
To introduce a C-terminal glycosylation site in the V18
and P18constructs (Fig. 3B), the templates were ampli-
fied as above but with a 3' primer encoding the C-termi-
nal sequence ...PTGLRLSNSTGIH(stop) corresponding
to the C-terminal end of Lep but with the underlined res-
idues changed to encode a glycosylation acceptor site.
MGD values (Fig. 4) were measured as described in [14]
for the L17V and V18 constructs, and also for a V18-de-
rived construct where the third Val from the N-terminal
end was replaced by Pro. Briefly, full-length constructs
with the Asn residue in a Asn-Ser-Thr glycosylation ac-
ceptor site placed 9-18 residues upstream of the respec-
tive hydrophobic segments were translated in vitro in
the presence of dog pancreas microsomes, and the MGD
value was determined from a plot of the efficiency of gly-
cosylation versus the position of the glycosylation site as
shown in Fig. 4.
Expression in vitro
Templates for in vitro transcription were prepared as de-
scribed in [23] or by PCR amplification with the pGEM1
construct as template as described above. Amplified PCR
fragments were transcribed from the SP6 promoter us-
ing the Large Scale RNA Synthesis kit with the RiboMAX
SP6 RNA polymerase system. Transcriptions were car-
ried out at 30° C for 12 hours. The mRNAs were purified
using Qiagen RNeasy clean up kit and verified on a 1%
agarose gel.
Translation in reticulocyte lysate in the presence of dog
pancreas microsomes was performed as described in
[23] at 30° C for 1 h (when generating full-length, proper-
ly terminated chains) or at 22° C for 30 min. (when gen-
erating truncated ribosome-nascent chain complexes).
Proteins were analyzed by SDS-PAGE and gels were
quantitated on a Fuji BAS1000 phosphoimager using the
MacBAS 2.31 software. The extent of glycosylation of a
given mutant was calculated as the quotient between the
intensity of the glycosylated band divided by the
summed intensities of the glycosylated and non-glyco-
sylated bands, or as the quotient between the intensities
of the doubly glycosylated band divided by the summed
intensities of the singly and doubly glycosylated bands
(for the experiment in Fig. 3B)
Translocation of polypeptides to the lumenal side of the
microsomes was assayed by resistance to exogenously
added proteinase K and by analysis of constructs with
two glycosylation acceptor sites flanking the model
polypeptide segments as in [24].
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